← Leaderboards

Jacques F Banchereau

Rockefeller University

Google Scholar ↗PubMed ↗ORCID ↗

$38,021,266

Attributed

$40,265,530

Total exposure

22

Grants

18

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $16.4M · FY2005–21

$20M$15M$10M$5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

Funding mix

By agency

NIH$79,029,137 · 24

By mechanism

U19$49,519,264 · 8

R01$9,640,681 · 5

U01$9,493,850 · 3

P50$5,471,545 · 2

P01$4,224,297 · 5

R21$679,500 · 1

Top collaborators

Octavio Ramilo6 shared

Most similar at Rockefeller University

Same institution · by research overlap

Shaopeng Yuan$173,423
Elena Ezhkova$13,754,048
Ali H Brivanlou$17,618,235
Eric D. Siggia$4,724,642
Danelle N Devenport$13,008,228

Others in their field

Top investigators on “Dendritic Cells”

Barton F Haynes · Duke University$112,608,041
Constance Ann Benson · University Of California, San Diego$65,790,143
David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
James C. Paulson · Scripps Research Institute$41,568,802
Ulrich H Von Andrian · Harvard Medical School$32,521,007
Donald L Morton · John Wayne Cancer Institute$29,042,629

Research focus

Dendritic CellsCellsVaccinesResponseB-LymphocytesBaseDesignImmunityImmuneImmune ResponseResearch PersonnelBloodImmune SystemCommunicable DiseasesVaccinationTechnologyFlow CytometryImmunologyProgramsGenetic TranscriptionCohortSamplingGenomicsTranscriptome

Grant awards (103)

Project 2: The Isoform repertoire and epigenome of Pediatric SLE$644,556

P50 · FY2021 · AR · contact PI

High-resolution single cell profiling of vaccine responsiveness in the elderly$567,504

R01 · FY2021 · AI · contact PI

High Precision System Analysis of Infant Immune Responses$1,668,904

U01 · FY2020 · AI

Project 2: The Isoform repertoire and epigenome of Pediatric SLE$644,556

P50 · FY2020 · AR · contact PI

Combination Adjuvants to Activate Human Dendritic Cell Subsets and B Cells$604,976

U01 · FY2020 · AI · contact PI

High-resolution single cell profiling of vaccine responsiveness in the elderly$578,151

R01 · FY2020 · AI · contact PI

High Precision System Analysis of Infant Immune Responses$526,213

U01 · FY2020 · AI

High Precision System Analysis of Infant Immune Responses$360,758

U01 · FY2020 · AI

Combination Adjuvants to Activate Human Dendritic Cell Subsets and B Cells$141,667

U01 · FY2020 · AI · contact PI

Combination Adjuvants to Activate Human Dendritic Cell Subsets and B Cells$1,088,630

U01 · FY2019 · AI · contact PI

Project 2: The Isoform repertoire and epigenome of Pediatric SLE$644,557

P50 · FY2019 · AR · contact PI

Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines$638,567

R01 · FY2019 · AG · contact PI

High-resolution single cell profiling of vaccine responsiveness in the elderly$600,281

R01 · FY2019 · AI · contact PI

High Precision System Analysis of Infant Immune Responses$522,868

U01 · FY2019 · AI

High Precision System Analysis of Infant Immune Responses$882,108

U01 · FY2018 · AI

Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines$643,216

R01 · FY2018 · AG · contact PI

Combination Adjuvants to Activate Human Dendritic Cell Subsets and B Cells$624,682

U01 · FY2018 · AI · contact PI

Project 2: The Isoform repertoire and epigenome of Pediatric SLE$708,947

P50 · FY2017 · AR · contact PI

Combination Adjuvants to Activate Human Dendritic Cell Subsets and B Cells$640,154

U01 · FY2017 · AI · contact PI

Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines$546,881

R01 · FY2017 · AG · contact PI

High Precision System Analysis of Infant Immune Responses$527,677

U01 · FY2017 · AI

Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines$189,000

R01 · FY2017 · AG · contact PI

Combination Adjuvants to Activate Human Dendritic Cell Subsets and B Cells$692,040

U01 · FY2016 · AI · contact PI

Project 2: The Isoform repertoire and epigenome of Pediatric SLE$642,478

P50 · FY2016 · AR · contact PI

Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines$519,649

R01 · FY2016 · AG · contact PI

Discretionary Funds$3,101,147

U19 · FY2013 · AI · contact PI

Targeting Dendritic Cells for Enhanced Musocal Immunity$242,013

U19 · FY2013 · AI · contact PI

Administration$98,620

U19 · FY2013 · AI · contact PI

Pilot Projects$92,466

U19 · FY2013 · AI · contact PI

Discretionary Funds$1,958,647

U19 · FY2012 · AI · contact PI

Targeting Dendritic Cells for Enhanced Musocal Immunity$409,924

U19 · FY2012 · AI · contact PI

Administration$160,513

U19 · FY2012 · AI · contact PI

Pilot Projects$107,888

U19 · FY2012 · AI · contact PI

Discretionary Funds$1,363,466

U19 · FY2011 · AI · contact PI

Targeting Dendritic Cells for Enhanced Musocal Immunity$382,868

U19 · FY2011 · AI · contact PI

Administration$226,053

U19 · FY2011 · AI · contact PI

Pilot Projects$189,154

U19 · FY2011 · AI · contact PI

Harnessing Human DC Subsets for Improved Muscosal Vaccines$4,812,281

U19 · FY2010 · AI · contact PI

Discretionary Funds$1,377,239

U19 · FY2010 · AI · contact PI

Harnessing Human DC Subsets for Improved Muscosal Vaccines$1,322,064

U19 · FY2010 · AI · contact PI

Targeting Dendritic Cells for Enhanced Musocal Immunity$386,736

U19 · FY2010 · AI · contact PI

Altered CD8+ T cell Compartment in SLE Patients$359,529

R01 · FY2010 · AI · contact PI

Monocytes in Lupus Pathogenesis$290,165

P50 · FY2010 · AR · contact PI

Administration$228,336

U19 · FY2010 · AI · contact PI

Improving the Efficacy of Dendritic Cell Vaccines$200,000

P01 · FY2010 · CA · contact PI

Pilot Projects$191,064

U19 · FY2010 · AI · contact PI

Harnessing Human DC Subsets for Improved Muscosal Vaccines$5,292,047

U19 · FY2009 · AI · contact PI

Harnessing Human DC Subsets for Improved Muscosal Vaccines$4,860,891

U19 · FY2009 · AI · contact PI

Harnessing Human DC Subsets for Improved Muscosal Vaccines$1,600,000

U19 · FY2009 · AI · contact PI

Discretionary Funds$1,393,179

U19 · FY2009 · AI · contact PI

Blood Transcriptional Biomarker Profiles for Category B Pathogens$1,213,173

U01 · FY2009 · AI · contact PI

Monocytes in Lupus Pathogenesis$574,642

P50 · FY2009 · AR · contact PI

Targeting Dendritic Cells for Enhanced Musocal Immunity$392,680

U19 · FY2009 · AI · contact PI

Altered CD8+ T cell Compartment in SLE Patients$363,160

R01 · FY2009 · AI · contact PI

Administration$232,669

U19 · FY2009 · AI · contact PI

Improving the Efficacy of Dendritic Cell Vaccines$200,000

P01 · FY2009 · CA · contact PI

Pilot Projects$195,020

U19 · FY2009 · AI · contact PI

Harnessing Human DC Subsets for Improved Muscosal Vaccines$48,970

U19 · FY2009 · AI · contact PI

Human Dendritic Cells and In Vivo Immunity to Biothreat$3,141,637

U19 · FY2008 · AI · contact PI

Improving the Efficacy of Dendritic Cell Vaccines$985,145

P01 · FY2008 · CA · contact PI

Human Dendritic Cell Subsets$950,220

U19 · FY2008 · AI · contact PI

Monocytes in Lupus Pathogenesis$403,996

P50 · FY2008 · AR · contact PI

Altered CD8+ T cell Compartment in SLE Patients$363,160

R01 · FY2008 · AI · contact PI

Subpopulations of Human Dendritic Cells$292,811

R01 · FY2008 · CA · contact PI

Pilot Project Component$231,755

U19 · FY2008 · AI · contact PI

Administrative Core$207,841

U19 · FY2008 · AI · contact PI

Increasing the Potency of CD-34-DC Vaccines$174,284

P01 · FY2008 · CA · contact PI

Core--Immunomonitoring$115,475

P01 · FY2008 · CA · contact PI

Core--Administration, Biostatistics, Data Management$36,885

P01 · FY2008 · CA · contact PI

Human Dendritic Cells and In Vivo Immunity to Biothreat$3,141,637

U19 · FY2007 · AI · contact PI

Improving the Efficacy of Dendritic Cell Vaccines$978,697

P01 · FY2007 · CA · contact PI

Monocytes in Lupus Pathogenesis$520,283

P50 · FY2007 · AR · contact PI

Altered CD8+ T cell Compartment in SLE Patients$370,194

R01 · FY2007 · AI · contact PI

Subpopulations of Human Dendritic Cells$292,811

R01 · FY2007 · CA · contact PI

Increasing the Potency of CD-34-DC Vaccines$173,353

P01 · FY2007 · CA · contact PI

Core--Immunomonitoring$114,481

P01 · FY2007 · CA · contact PI

Core--Administration, Biostatistics, Data Management$36,604

P01 · FY2007 · CA · contact PI

Human Dendritic Cells and In Vivo Immunity to Biothreat$3,148,010

U19 · FY2006 · AI · contact PI

Improving the Efficacy of Dendritic Cell Vaccines$999,999

P01 · FY2006 · CA · contact PI

Monocytes in Lupus Pathogenesis$397,365

P50 · FY2006 · AR · contact PI

Altered CD8+ T cell Compartment in SLE Patients$381,250

R01 · FY2006 · AI · contact PI

Subpopulations of Human Dendritic Cells$301,556

R01 · FY2006 · CA · contact PI

Increasing the Potency of CD-34-DC Vaccines$111,981

P01 · FY2006 · CA · contact PI

Core--Immunomonitoring$73,790

P01 · FY2006 · CA · contact PI

Core--Administration, Biostatistics, Data Management$23,603

P01 · FY2006 · CA · contact PI

Human Dendritic Cells and In Vivo Immunity to Biothreat$3,124,596

U19 · FY2005 · AI

Subpopulations of Human Dendritic Cells$308,813

R01 · FY2005 · CA

Human Dendritic Cells and In Vivo Immunity to Biothreat$3,164,316

U19 · FY2004 · AI

Subpopulations of Human Dendritic Cells$309,065

R01 · FY2004 · CA

Dendritic Cells, Heat Shock Proteins and Tumor Immunity$250,660

R01 · FY2004 · CA

Human Dendritic Cells and In Vivo Immunity to Biothreat$1,743,317

U19 · FY2003 · AI

SUBPOPULATIONS OF HUMAN DENDRITIC CELLS$261,402

R01 · FY2003 · CA

Dendritic Cells, Heat Shock Proteins and Tumor Immunity$250,660

R01 · FY2003 · CA

Dendritic Cell Vaccine in Metastatic Prostate Cancer$339,750

R21 · FY2002 · CA

SUBPOPULATIONS OF HUMAN DENDRITIC CELLS$255,765

R01 · FY2002 · CA

Dendritic Cells, Heat Shock Proteins and Tumor Immunity$250,660

R01 · FY2002 · CA

Induction of melanoma immunity by dendritic cell subsets$0

P01 · FY2002 · CA

Dendritic Cell Vaccine in Metastatic Prostate Cancer$339,750

R21 · FY2001 · CA

Dendritic Cells, Heat Shock Proteins and Tumor Immunity$250,660

R01 · FY2001 · CA

SUBPOPULATIONS OF HUMAN DENDRITIC CELLS$250,294

R01 · FY2001 · CA

Induction of melanoma immunity by dendritic cell subsets$0

P01 · FY2001 · CA

SUBPOPULATIONS OF HUMAN DENDRITIC CELLS$244,982

R01 · FY2000 · CA

Induction of melanoma immunity by dendritic cell subsets$0

P01 · FY2000 · CA